ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Ameri Holdings Inc

Ameri Holdings Inc (AMRH)

1.48
0.00
(0.00%)
Closed July 20 4:00PM
0.00
0.00
(0.00%)

Empower your portfolio: Real-time discussions and actionable trading ideas.

AMRH News

Official News Only

AMRH Discussion

View Posts
MrFan2c MrFan2c 4 years ago
Just Wow! I've taken some round trips before but never that far that fast. Yesterday Tikun Olam's value flexed it's muscle. I think the mention of a reverse split scared everyone today. I don't think there will even be a reverse split unless absolutely necessary for their Nasdaq eligibility. With the tiny float I believe yesterday's high was just a warm up of what's to come.
👍️0
ClayTrader ClayTrader 4 years ago
* * $AMRH Video Chart 12-28-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
wesley_ wesley_ 4 years ago
$2.30 nice
👍️0
MrFan2c MrFan2c 4 years ago
Vote to complete merger is on 12/23.20. Tikun Olam has potential to be as good or better than than GW Pharma.
👍️0
MAKESOME79 MAKESOME79 4 years ago
$AMRH Super Play. This is a hot low float driving stock play for Monday! Could see. 200% Gain. Second High watch. $WORX see two day volume gains. Large Momentum moving. Could also 200% Gain. Both Strong Buys.
👍️0
INTL INTL 4 years ago
Agree
This is a great set up. Will be accumulating into merger. MJ and CBD are heating up with the transition in the White House. The perfect storm for this small float.
Good Luck
👍️0
MAKESOME79 MAKESOME79 4 years ago
AMERI Holdings Declares Form S-4 Related To Co.'s Tender Deal With Jay Pharma To Be Effective low float 10 bagger.

👍️0
whytestocks whytestocks 4 years ago
NEWS: $AMRH Are These On Your List Of Penny Stocks To Buy Or Sell In October?

Which Penny Stocks Are On Your List? When it comes to penny stocks , you should be prepared for a road of volatility. These stocks under $5 can easily move 50% in any direction in a single day. Trading penny stocks could be difficult if you don’t take the time for it thou...

In case you are interested AMRH - Are These On Your List Of Penny Stocks To Buy Or Sell In October?
👍️0
Liquid1974 Liquid1974 4 years ago
Pr pm or am?....
👍️0
Liquid1974 Liquid1974 4 years ago
Added on my volume scanner...
👍️0
TFMG TFMG 4 years ago

$AMRH | #AmeriHoldings Bullish Setup



Ameri Holdings , Inc. is a technology services company, which specializes in systems, applications, and products (SAP) cloud, digital, and enterprise services. It offers technology consulting; business intelligence; cloud services; application development, integration, and maintenance; implementation services; infrastructure services; and independent validation services. The company was founded by Srinidhi Devanur in February 1994 and is headquartered in Suwanee, GA.


👍️0
stock1ace1 stock1ace1 4 years ago
July 1, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) ("Ameri" or the "Company"), announced that the Company is continuing to work through the regulatory review process towards finalizing the proposed amalgamation transaction with Jay Pharma, Inc. ("Jay Pharma"),
👍️0
stock1ace1 stock1ace1 4 years ago
2.7 Mill Float
👍️0
stock1ace1 stock1ace1 4 years ago
3 Mill o/s Pending Deal Closing ~>


Pending Transaction With Jay Pharma Inc. ATLANTA , July 1, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) ("Ameri" or the "Company"), announced that the Company is continuing to work through the regulatory review process towards finalizing the proposed amalgamation transaction with Jay Pharma, Inc. ("Jay Pharma"),
👍️0
whytestocks whytestocks 4 years ago
News: $AMRH Ameri Holdings Provides Update On Pending Transaction With Jay Pharma Inc.

ATLANTA , July 1, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) ("Ameri" or the "Company"), announced that the Company is continuing to work through the regulatory review process towards finalizing the proposed amalgamation transaction with Jay Pharma, Inc. ("Jay Pharma"),...

In case you are interested AMRH - Ameri Holdings Provides Update On Pending Transaction With Jay Pharma Inc.
👍️0
Hawkeye_tt Hawkeye_tt 4 years ago
News ??
👍️0
Hawkeye_tt Hawkeye_tt 4 years ago
LOL...got us.
Congratzz on who sold on pop.
Holding a Bag here still....

Hawk
👍️0
ars_2014 ars_2014 4 years ago
Pump and dump

Next one is $RLBY
👍️0
ars_2014 ars_2014 4 years ago
This was all a pump and dump

Same people involved in AMRH are also involved with RLBY (next pump)

Buy RLBY for the next PUMP!
👍️0
ClayTrader ClayTrader 4 years ago
* * $AMRH Video Chart 06-02-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
Roadtojourney Roadtojourney 4 years ago
Well the question is would it even stay above 3??
👍️0
Hawkeye_tt Hawkeye_tt 4 years ago
Retrace on spike.
Watch for turn.

Hawk
👍️0
Roadtojourney Roadtojourney 4 years ago
Dosent matter i bought it and started going down, not sure if this will go up again unless i sell lol
👍️0
Hawkeye_tt Hawkeye_tt 4 years ago
Vol. 43 M already.
👍️0
Hawkeye_tt Hawkeye_tt 4 years ago
AMERI Holdings Amalgamation Partner Jay Pharma Reports IRB Approval For Testing Proprietary CBD Formulation In Brain Cancer
June 02 2020 - 09:00AM
PR Newswire (US) Print
ATLANTA, June 2, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) (the "Company"), today announced that its proposed amalgamation partner Jay Pharma Inc. ("Jay Pharma") received institutional review board ("IRB") approval by Rabin Medical Center in Petah Tikva, Israel for a Phase I/II clinical trial investigating Jay Pharma's proprietary cannabidiol ("CBD") formulation for the treatment of glioblastoma multiforme ("GBM"), a rare and aggressive form of brain cancer. This open-label, two-arm, randomized, prospective study is scheduled to commence following final approval from the Israel Ministry of Health, which is expected this summer.
👍️0
Awl416 Awl416 4 years ago
Wild
👍️0
Full Contact Yoga Full Contact Yoga 4 years ago
Actually, with this float, a well orchestrated, well compensated, P and D could move this quite a bit. They might try it, ethics has never been one of their corporate qualities...
👍️0
Full Contact Yoga Full Contact Yoga 4 years ago
Wonder if this road to nowhere POS is trying to resurrect. Could move, with a big budget P and D...
👍️0
KoenigSalomon KoenigSalomon 4 years ago
10 bagger
👍️0
ars_2014 ars_2014 4 years ago
You should post on RLBY board.

He is a fraudster who belongs in jail. His fund was closed down because he was a terrible investor.
👍️0
Narada Muni Narada Muni 4 years ago

Ladies and Gentlemen,

Please check this out:

Jeffrey Eberwein's fraud has been exposed and he has been sued!

https://ws.onehub.com/files/awm81zww

Beware of your investment!!
👍️0
Hawkeye_tt Hawkeye_tt 4 years ago
News is what ??

Hawk
👍️0
Hawkeye_tt Hawkeye_tt 4 years ago
Action EOD and AH....bidder at Table finally ?!

Hawk
👍️0
eebbee eebbee 4 years ago
Halted for volatility, for some reason.
👍️0
KoenigSalomon KoenigSalomon 5 years ago
On the one hand AMRH CFO very weak on the other hand Jay CEO very inspiring.

I was missing some facts like
- whats the compensation for IT business
- what happens with liabilities, receivables etc
- actual Revenue & Profit of Jay Pharma
- dividend to shareholders

and a lot more.

No transparency for now.... hopefully authorities and shareholders will not approve this status.
For now I feel the old shareholders are hornswoggled by fraudsters.

KS



👍️0
Hawkeye_tt Hawkeye_tt 5 years ago
AH...$1.86.
Someone like the call?!

Hawk
👍️0
Hawkeye_tt Hawkeye_tt 5 years ago
Anyone dial in ??
👍️0
Vet-trader Vet-trader 5 years ago
That is how the company ads share holder value what a bunch of A-holes.
👍️0
Full Contact Yoga Full Contact Yoga 5 years ago
Basically, spin all value out of the shell, screw commons, dump shell on POS company, live to scam again. Not their first rodeo...
👍️0
Hawkeye_tt Hawkeye_tt 5 years ago
CC announced....yep, explain this to us...

AMERI Holdings, Inc. (NASDAQ: AMRH) (“Ameri”), will host a conference call and webcast at 4:15 p.m. ET on Thursday, January 16, 2020, to discuss its entry into an amalgamation agreement (the “transaction”) announced today whereby the shareholders of Jay Pharma will become the majority holders of Ameri’s outstanding stock.
👍️0
ars_2014 ars_2014 5 years ago
Same folks involved with $RLBY
👍️0
ars_2014 ars_2014 5 years ago
It seems like it’s all the same; folks from India running a pump and dump shell.
👍️0
ars_2014 ars_2014 5 years ago
The founders of this shell is also running the same shell $RLBY

Do the research
👍️0
Full Contact Yoga Full Contact Yoga 5 years ago
So, basically, scam commons, spin out anything of value, leave the shell...sounds like a typical POS OTC scam rather than an actual company, not surprised, but pathetically sad all the same...
👍️0
JBInvesting JBInvesting 5 years ago
I guess this means they will never be Google certified!
👍️0
Hawkeye_tt Hawkeye_tt 5 years ago
So much for the IT part.....

In connection with the Amalgamation, Ameri will spin-off its existing IT services business to a private entity founded by Ameri management in partnership with Ameri’s current Series A Preferred Equity Holders (the “Spin-Off,” and collectively, with the Amalgamation, the “Transactions”). The Transactions are expected to close in the first half of 2020, subject to Ameri shareholder approval, approval of the Nasdaq Stock Market, and other customary closing conditions.
👍️0
Hawkeye_tt Hawkeye_tt 5 years ago
AMERI Holdings, Inc. (NASDAQ: AMRH) (“Ameri”) today announced it entered into an amalgamation agreement (the “Amalgamation Agreement”) with Jay Pharma Inc. (“Jay Pharma”), a Canadian company dedicated to developing innovative, evidence-based cannabinoid products and combination therapies to address unmet needs in cancer care, pursuant to which the shareholders of Jay Pharma will become the majority holders of Ameri’s outstanding stock by way of an amalgamation (the “Amalgamation”). In connection with the Amalgamation, Ameri will spin-off its existing IT services business to a private entity founded by Ameri management in partnership with Ameri’s current Series A Preferred Equity Holders (the “Spin-Off,” and collectively, with the Amalgamation, the “Transactions”). The Transactions are expected to close in the first half of 2020, subject to Ameri shareholder approval, approval of the Nasdaq Stock Market, and other customary closing conditions.
“We are excited about the Jay Pharma business and believe that it is a great opportunity that will maximize shareholder value,” said Dev Nidhi, Executive Chairman of Ameri.

On a pro forma basis and based upon the number of shares of Ameri common stock to be issued in the Amalgamation, current Ameri shareholders will own approximately 16% of the combined company and current Jay Pharma shareholders will own approximately 84% of the combined company. The Boards of Directors of both Ameri and Jay Pharma have unanimously approved the transaction.

Jay Pharma is primarily focused on developing over-the-counter cannabinoid-based palliative and wellness products to address the side effects of cancer and cancer treatment, including skin reactions, pain, nausea, and anxiety. Jay Pharma holds the exclusive rights to Israel-based Tikun Olam Ltd.’s (“Tikun Olam”) proprietary cannabinoid genetics and data for oncology, including for the development of over-the-counter and pharmaceutical products. Tikun Olam has amassed one of the world’s largest patient treatment databases in the field of medical cannabis, with over 20,000 patient records noting strains used and symptoms treated. Use of Tikun Olam strains were analyzed in 2,970 cancer patients seeking assistance with sleep problems, pain, nausea, and lack of appetite (Bar-lev Schleider, Eur J Intern Med, 2018); treatment was found to be a well-tolerated, effective, and safe option to help patients cope with the malignancy related symptoms. Jay Pharma plans to bring leading oncology clinicians and researchers, together with academic and industry partners to enhance clinically proven products to patients. In addition, Jay Pharma has an experienced management team led by Dave Johnson who will assume the Chairman & CEO role upon the closing of the Transactions.
👍️0
Hawkeye_tt Hawkeye_tt 5 years ago
Interest at the Table ?!
👍️0
Crazy Money Crazy Money 5 years ago
Hmmm...
👍️0
Hawkeye_tt Hawkeye_tt 5 years ago
Going to see our morning buyer again today ?

Hawk
👍️0

Your Recent History

Delayed Upgrade Clock